Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Conatus Pharmaceuticals Inc    CNAT

CONATUS PHARMACEUTICALS INC

(CNAT)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on CONATUS PHARMACEUTICALS IN
06/27/19 Annual General Meeting
08/05/19 Interim 2019 Earnings Release (Projected)
11/11/19 Q3 2019 Earnings Release (Projected)
03/11/20 FY 2019 Earnings Release (Projected)
Past events on CONATUS PHARMACEUTICALS IN
05/02/19 Q1 2019 Earnings Release
04/13/19 | 10:00am International Liver Congress
04/09/19 | 05:30am H. C. Wainwright Global Life Sciences Conference
03/08/19 | 04:30pm FY 2018 Earnings Call
Upcoming sector events for CONATUS PHARMACEUTICALS IN
06/20/19 QIAGEN NV : American Society of Microbiology Meeting
06/20/19 GENMAB A/S : JP Morgan European Health Care Conference
06/20/19 | 03:00am SEATTLE GENETICS, INC. : Malignant Lymphoma International Conference - Abstract #237
06/20/19 | 08:00am BEIGENE LTD : Malignant Lymphoma International Conference
More events
Past sector events for CONATUS PHARMACEUTICALS IN
06/19/19 BEIGENE LTD : Malignant lymphoma international conference - abstract code: 191
06/19/19 | 06:00am SEATTLE GENETICS, INC. : Malignant lymphoma international conference - abstract: #235
06/19/19 | 11:25am SEATTLE GENETICS, INC. : Malignant Lymphoma International Conference - Abstract #025
06/19/19 | 11:35am SEATTLE GENETICS, INC. : Malignant lymphoma international conference - abstract: #026
Annual publications
Previous yearNext Year
Annual results2016201720182019 (e)2020 (e)
Sales
Million $
Released
Forecast
Spread
0,80
1,43
-44%
35,4
36,2
-2,4%
33,6
34,8
-3,5%

25,5

12,2
Operating income (EBITDA)
Million $
Released
Forecast
Spread


-17,4
3,67
-575%






Operating profit (EBIT)
Million $
Released
Forecast
Spread
-29,8
-23,9
-25%
-17,6
-18,2
3,8%
-18,3
-18,6
1,9%

-20,2

-22,2
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-29,7
-26,3
-13%
-17,4
-18,0
3,6%
-18,0
-18,4
2,3%

-19,7

-21,8
Net income
Million $
Released
Forecast
Spread
-29,7
-26,5
-12%
-17,4
-18,0
3,6%
-18,0
-18,4
2,3%

-19,7

-21,8
EPS
 $
Released
Forecast
Spread
-1,31
-1,22
-7,0%
-0,61
-0,64
4,9%
-0,59
-0,61
3,3%

-0,51

-0,49
Announcement Date03/15/201703/07/201803/08/2019

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ3
2018
Q4
2018
Q1
2019
Q2
2019 (e)
Q3
2019 (e)
Sales
Million $
Released
Forecast
Spread
7,67
9,78
-22%
7,41
8,63
-14%
7,02
8,26
-15%

7,05

6,65
Operating income (EBITDA)
 
Released
Forecast
Spread










Operating profit (EBIT)
Million $
Released
Forecast
Spread
-4,66
-4,63
-0,51%
-4,01
-4,35
8,0%
-4,95
-3,86
-28%

-4,87

-4,58
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-4,59
-4,64
1,1%
-3,91
-4,34
10%
-4,75
-3,77
-26%

-4,79

-4,43
Net income
Million $
Released
Forecast
Spread
-4,59
-4,64
1,1%
-3,91
-4,34
10%
-4,75
-3,77
-26%

-4,79

-4,43
EPS
 $
Released
Forecast
Spread
-0,15
-0,15
2,6%
-0,13
-0,14
9,7%
-0,14
-0,12
-17%

-0,15

-0,11
Announcement Date11/01/201803/08/201905/02/2019

© 2019 Thomson Reuters
© 2019 Factset
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
Operating profit (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise